Tuesday, November 5, 2024
HomeTagsSubcutaneous bispecific antibody

subcutaneous bispecific antibody

EPKINLY Approved by U.S. FDA as the First and Only Bispecific Antibody to Treat Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved EPKINLY, as the first and only T-cell engaging bispecific antibody for the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics